Beam Therapeutics (NasdaqGS:BEAM) Q4 2025 Earnings call February 24, 2026 08:00 AM ET Company ParticipantsAditya Lonial - Senior Managing DirectorAlec Stranahan - VP of Equity ResearchAmy Simon - Chief Medical OfficerGiuseppe Ciaramella - PresidentGopi Shanker - Chief Scientific OfficerHolly Manning - Vice President of Investor Relations and External CommunicationsJohn Evans - CEOKiran Musunuru - Professor of MedicineSravan Emany - CFOYannan Liu - Equity Research AssociateConference Call ParticipantsBrian C ...

Beam Therapeutics (NasdaqGS:BEAM) Q4 2025 Earnings call February 24, 2026 08:00 AM ET Company ParticipantsAditya Lonial - Senior Managing DirectorAlec Stranahan - VP of Equity ResearchAmy Simon - Chief Medical OfficerGiuseppe Pino Ciaramella - PresidentGopi Shanker - Chief Scientific OfficerHolly Manning - Vice President of Investor Relations and External CommunicationsJohn Evans - CEOKiran Musunuru - Professor of MedicineSravan Emany - CFOYannan Liu - Equity Research AssociateConference Call ParticipantsBr ...

Beam Therapeutics (NasdaqGS:BEAM) Q4 2025 Earnings call February 24, 2026 08:00 AM ET Speaker14Good morning, and welcome to Beam Therapeutics conference call. At this time, all participants are in a listen-only mode. There will be a question and answer session at the end. Please be advised that this call is being recorded at Beam's request. I would now like to turn the call over to Holly Manning, Vice President of Investor Relations and External Communications. Please go ahead.Speaker9Thank you, operator. G ...